Figure 2. The incidence of aGVHD after allogeneic HSCT increased in patients infused percentage of CD4+CD25-CD69+ Treg less than 1.08%.
Figure 2

The incidence of aGVHD after allogeneic HSCT increased in patients infused percentage of CD4+CD25-CD69+ Treg less than 1.08%.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal